News

Published on 14 Nov 2023 on GuruFocus.com via Yahoo Finance

FMR LLC Adjusts Stake in Vera Therapeutics Inc


Article preview image

Recent Transaction Overview

On October 31, 2023, investment firm FMR LLC (Trades, Portfolio) made a notable adjustment to its holdings in Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company. The firm reduced its position by 2,137,756 shares, resulting in a remaining total of 3,307,610 shares. Despite this significant change, the transaction did not have a material impact on FMR LLC (Trades, Portfolio)'s portfolio, with the trade impact recorded at 0%. The shares were traded at a price of $10.42 each on the date of the transaction.

FMR LLC (Trades, Portfolio)'s Investment Profile

NASDAQ.VERA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing...

GuruFocus.com via Yahoo Finance 12 Apr 2024

Vera Therapeutics executive sells over $228k in company stock

In a recent transaction, Joseph R. Young, the Senior Vice President of Finance and Chief Accounti...

Investing.com 11 Apr 2024

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact -...

On Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences I...

Benzinga 11 Apr 2024

Vertex Pharma’s takeover of Alpine Immune is a strategic fit: analysts

Alpine Immune’s lead candidate is being evaluated as a potential treatment for IgA Nephropathy, o...

Market Watch 11 Apr 2024

Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer

(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total ...

Bloomberg via Yahoo Finance 11 Apr 2024

Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vera Therapeutics fair value estimate is...

Simply Wall St. via Yahoo Finance 11 Feb 2024

FMR LLC Adjusts Stake in Vera Therapeutics Inc

Recent Transaction Overview On October 31, 2023, investment firm FMR LLC (Trades, Portfolio) made...

GuruFocus.com via Yahoo Finance 14 Nov 2023

Wall Street Analysts Believe Vera Therapeutics, Inc. (VERA) Could Rally 86.76%: Here's is How to...

Vera Therapeutics, Inc. (VERA) closed the last trading session at $12.76, gaining 23.4% over the ...

Zacks via Yahoo Finance 14 Nov 2023

Down -34.74% in 4 Weeks, Here's Why You Should You Buy the Dip in Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA) has been on a downward spiral lately with significant selling pres...

Zacks via Yahoo Finance 18 Oct 2023

What Makes Vera Therapeutics, Inc. (VERA) a New Buy Stock

Vera Therapeutics, Inc. (VERA) appears an attractive pick, as it has been recently upgraded to a ...

Zacks via Yahoo Finance 15 Aug 2023